Tysabri Clears FDA For Moderate To Severe Crohn’s Disease
Natalizumab will be available for patients with Crohn’s disease by the end of February, Biogen Idec/Elan say.
Natalizumab will be available for patients with Crohn’s disease by the end of February, Biogen Idec/Elan say.